Authors
Latest:
Addressing the Knowledge Gap in Biologics & Biosimilars: Is a Board Certified Biologics and Biosimilars Program the Answer?Life sciences professionals will need to keep up with market demand for biologics and biosimilars.
Latest:
Delivering Brand Relevancy through Connected Data and AnalyticsHow a large, global biopharma company is leveraging a data-linking strategy to power insight-generation tools and techniques—and supporting customers through their journey with dynamic personalization and modular content.
Latest:
Delivering Medical Affairs Value Through Omnichannel OrchestrationLearnings from a roundtable discussion with Medical Affairs leadership from 11 pharma companies
Latest:
Harnessing the Value of AI In Customer EngagementBy using correct data and pertinent ML algorithms, customer engagement leaders can identify deep insights into customer behavior and make the right interventions to transform the customer experience.
Latest:
Building an Optimal Patient Support TeamHow effective training programs enable ‘next-generation’ patient engagement.
Latest:
Using Identity Resolution Technology to Dispense Hyper-Relevant Information to HCPsHealthcare professionals (HCPs) shouldn’t miss out on critical information while their focus is on their patients, which is why messages on professional platforms are an essential resource to improve a patient’s health results, writes Gareth Shaw.
Latest:
Boosting Clinical Trials and Patient Access with Payer InsightsClinical studies are increasingly designed to satisfy evidentiary needs.
Latest:
Delivery and Disruption: Navigating a Changing Care TerrainThe diversification of site-of-care delivery models is accelerating rapidly, creating new go-to-market implications for drug manufacturers—but also new opportunities to drive more fundamental innovation in engagement and access strategies.
Latest:
Strategic Decision-Making in Early-Stage Drug Development and Lifecycle Management to Maximize a Drug’s Lifetime ValuePresenting a structured, decision-making approach for executive management to make sound strategic decisions for drug development and life cycle management.
Latest:
Succession Attack Plan: Get Strategic with Your Critical RolesOutlining four considerations for biopharma companies in ensuring that their approach to replacing and filling key leadership positions is more truly aligned with future goals in business delivery and risk management.
Latest:
From Potential to Value: Carving a Slice of the CGT ‘PIE'The importance of pre-approval information exchange (PIE) with payers and other strategic considerations to help navigate today’s market access challenges and regulatory requirements in bringing promising cell and gene therapies to the market.
Latest:
This is Your Wake-Up Call–Sunshine Act Enforcement is HereMitigating potential risk for stakeholders in light of latest Sunshine Act developments.
Latest:
The Importance of Opinion Leader-Content in a Digital TransformationMarketers are working to reimagine how they leverage key opinion leader (KOL) support during COVID-19.
Latest:
Identifying Healthcare Trends from Conversation DataHealthcare customers and patients are facing more avenues to receive misinformation about drugs than ever before.
Latest:
Evolving Client/Agency Model Beyond Just a Menu of CapabilitiesAre you working with a network or a committee?
Latest:
Talent Management Strategies for Post-Milestone GrowthInsights from Takeda, Jazz, Nestlé Health Sciences, Humana, and other healthcare executives
Latest:
Developing Patient-Focused Solutions: How a Multi-Modality Approach to Drug Discovery and Development is Driving Transformative InnovationWhen considering factors like disease biology and patient needs in drug discovery and development, the goal is to deliver effective and scalable treatments globally by balancing established approaches like small molecules or protein therapeutics with more complex modalities such as RNA, cell, and gene therapies.
Latest:
3 ASCO Insights for Pharma CommunicatorsThe world’s largest cancer research meeting, the American Society of Clinical Oncology (ASCO) Annual Meeting, recently convened in person in Chicago after two years of being held virtually. Sara Baker and Kristine Austria Fan of Marina Maher Communications provide their takeaways from the meeting.
Latest:
'Faster, Please': Key Challenges in Chemicals and Materials R&DCompanies must address myriad challenges to improve upon issues such as data quality and transparency, process efficiency, and artificial intelligence/machine learning preparedness.
Latest:
The Complementary Role of Real-World Evidence and Clinical Trials in Addressing Unmet Needs for IBD PatientsPatients with Crohn's disease and ulcerative colitis face a high disease burden.
Latest:
Omnichannel Marketing Challenges for European Life Sciences Companies: A Data Science PerspectiveAs EU brand leaders build their omnichannel customer engagement strategies, they need to address challenges in the European environment with a well-thought-out deployment plan.
Latest:
How Technology Can be Used to Improve AdherenceComprehensive dosage monitoring of topical treatments for mild to moderate psoriasis.
Latest:
Social Determinants of Health Data Evolution: Improve Access, Adherence and Achieve More Equitable OutcomesWebinar Date/Time: Tue, May 16, 2023 2:00 PM EDT
